Orthotopic cardiac transplantation in a Veterans Administration hospital.
Of 57 patients referred to the McGuire Veterans Administration Medical Center, Richmond, Va, for evaluation for cardiac transplantation, 18 received allografts. The overall graft survival rate was 67% from two to 24 months after transplantation. In 15 recipients receiving immunosuppression with rabbit anti-human thymocyte globulin, prednisone, and azathioprine, previous transfusion and HLA-DR matching resulted in improved graft survival. In three patients receiving cyclosporin and prednisone, hypertension, nephrotoxicity, and hepatotoxicity were seen. All surviving recipients were in functional New York Heart Association class 1 or 2. The cost to the Medical Center was $23,275 per transplant. The results achieved at the center suggested that a regionalized cardiac transplant program can be established within the VA health care system with acceptable clinical results and significant financial savings.
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D005240:Feasibility Studies; D006084:Graft Rejection; D006085:Graft Survival / Q000187:drug effects; D016027:Heart Transplantation; D006787:Hospitals, Veterans; D006801:Humans; D008297:Male; D010865:Pilot Projects; D011241:Prednisone / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology; D014768:Virginia
D000961:Antilymphocyte Serum; D001379:Azathioprine; D011241:Prednisone